EU patent approved for ChemStress®

18 March 2021

One of ValitaCell's key goals is to improve process control for cell based manufacturing systems which is why . ChemStress® Fingerprinting was developed. ChemStress® is a novel platform technology which characterises cells using a panel of specific, small molecule chemical stressors. Combining ChemStress® biological relevant outputs with Deep Learning and AI we support our customers to achieve the highest levels of bioprocess performance. The EU has recognised the uniqueness of ChemStress® with the approval of a new patent.

The EU patent is: No. 3014268

'A method of determining or predicting a characteristic of a cell'